264 related articles for article (PubMed ID: 25767870)
1. Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue.
Jones AC; Antillon KS; Jenkins SM; Janos SN; Overton HN; Shoshan DS; Fischer EG; Trujillo KA; Bisoffi M
PLoS One; 2015; 10(3):e0119314. PubMed ID: 25767870
[TBL] [Abstract][Full Text] [Related]
2. Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization.
Jones AC; Trujillo KA; Phillips GK; Fleet TM; Murton JK; Severns V; Shah SK; Davis MS; Smith AY; Griffith JK; Fischer EG; Bisoffi M
Prostate; 2012 Aug; 72(11):1159-70. PubMed ID: 22127986
[TBL] [Abstract][Full Text] [Related]
3. Prostate field cancerization and exosomes: Association between CD9, early growth response 1 and fatty acid synthase.
Amirrad F; Pytak PA; Sadeghiani-Pelar N; Nguyen JPT; Cauble EL; Jones AC; Bisoffi M
Int J Oncol; 2020 Apr; 56(4):957-968. PubMed ID: 32319557
[TBL] [Abstract][Full Text] [Related]
4. Differential gene expression in tumor adjacent histologically normal prostatic tissue indicates field cancerization.
Haaland CM; Heaphy CM; Butler KS; Fischer EG; Griffith JK; Bisoffi M
Int J Oncol; 2009 Sep; 35(3):537-46. PubMed ID: 19639174
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues.
Nakamura T; Scorilas A; Stephan C; Yousef GM; Kristiansen G; Jung K; Diamandis EP
Br J Cancer; 2003 Apr; 88(7):1101-4. PubMed ID: 12671711
[TBL] [Abstract][Full Text] [Related]
6. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
7. Spindle pole body component 25 and platelet-derived growth factor mediate crosstalk between tumor-associated macrophages and prostate cancer cells.
Cui F; Xu Z; Hu J; Lv Y
Front Immunol; 2022; 13():907636. PubMed ID: 35967419
[TBL] [Abstract][Full Text] [Related]
8. Association and regulation of protein factors of field effect in prostate tissues.
Gabriel KN; Jones AC; Nguyen JP; Antillon KS; Janos SN; Overton HN; Jenkins SM; Frisch EH; Trujillo KA; Bisoffi M
Int J Oncol; 2016 Oct; 49(4):1541-1552. PubMed ID: 27634112
[TBL] [Abstract][Full Text] [Related]
9. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors.
Chandran UR; Dhir R; Ma C; Michalopoulos G; Becich M; Gilbertson J
BMC Cancer; 2005 May; 5():45. PubMed ID: 15892885
[TBL] [Abstract][Full Text] [Related]
10. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice.
Husaini Y; Lockwood GP; Nguyen TV; Tsai VW; Mohammad MG; Russell PJ; Brown DA; Breit SN
PLoS One; 2015; 10(2):e0115189. PubMed ID: 25695521
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
George D
Semin Oncol; 2001 Oct; 28(5 Suppl 17):27-33. PubMed ID: 11740804
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate.
Patrikainen L; Porvari K; Kurkela R; Hirvikoski P; Soini Y; Vihko P
Eur J Clin Invest; 2007 Feb; 37(2):126-33. PubMed ID: 17217378
[TBL] [Abstract][Full Text] [Related]
13. The interplay of growth differentiation factor 15 (GDF15) expression and M2 macrophages during prostate carcinogenesis.
Sadasivan SM; Chen Y; Gupta NS; Han X; Bobbitt KR; Chitale DA; Williamson SR; Rundle AG; Tang D; Rybicki BA
Carcinogenesis; 2020 Aug; 41(8):1074-1082. PubMed ID: 32614434
[TBL] [Abstract][Full Text] [Related]
14. Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.
Rasiah KK; Kench JG; Gardiner-Garden M; Biankin AV; Golovsky D; Brenner PC; Kooner R; O'neill GF; Turner JJ; Delprado W; Lee CS; Brown DA; Breit SN; Grygiel JJ; Horvath LG; Stricker PD; Sutherland RL; Henshall SM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):711-6. PubMed ID: 16614113
[TBL] [Abstract][Full Text] [Related]
15. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia.
Iacopino AM; Doxey D; Cutler CW; Nares S; Stoever K; Fojt J; Gonzales A; Dill RE
J Periodontol; 1997 Jan; 68(1):73-83. PubMed ID: 9029455
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
17. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS
Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva.
Nares S; Ng MC; Dill RE; Park B; Cutler CW; Iacopino AM
J Periodontol; 1996 Mar; 67(3):271-8. PubMed ID: 8708960
[TBL] [Abstract][Full Text] [Related]
19. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
20. Macrophage inhibitory cytokine 1 biomarker serum immunoassay in combination with PSA is a more specific diagnostic tool for detection of prostate cancer.
Li J; Veltri RW; Yuan Z; Christudass CS; Mandecki W
PLoS One; 2015; 10(4):e0122249. PubMed ID: 25853582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
